CMR Surgical has launched the Ultrasonic Dissector, a robotic advanced energy instrument delivering ultrasonic energy to cut and coagulate tissue, as part of its Versius Plus offering.
The dissector is the first instrument in the advanced energy instrument range for the Versius Plus, the latest iteration of the modular and portable Versius robot. It was developed to deliver ultrasonic energy via a torsional design, and can seal vessels up to 5mm in diameter, with a mean burst pressure of 908mmHg – 7.5 times that of normal systolic blood pressure.
CMR Surgical’s Ultrasonic Dissector for Versius Plus
The Ultrasonic Dissector promotes haemostatic coagulation and simultaneous cutting with multiple, surgeon-selectable modes to suit each procedural need, supporting surgeons through more complex surgical procedures.
The introduction of the Ultrasonic Dissector to the Versius instrument suite completes a series of product launches made as part of Versius Plus, which was launched in February 2024. These include an expanded instrument portfolio, improved console, advanced digital insights, and vLimeLite, a fluorescent imaging system for the visualisation of ICG (indocyanine green is a sterile nontoxic dye used in a variety of medical procedures).
CMR Surgical’s Ultrasonic Dissector for Versius Plus
Mark Slack, chief medical officer and co-founder at CMR Surgical, said: “The introduction of the Ultrasonic Dissector is an important next step in our instrument portfolio.
“We’ve worked closely with our clinical partners to bring this proven ultrasonic instrument to Versius and are looking forward to seeing the positive impact it will have for surgeons using Versius.
“As a multifunctional instrument, Ultrasonic Dissector provides enhanced capability to Versius, allowing surgeons to seal blood vessels – supporting them to do more complex procedures with the system and thereby bring more robotic-assisted minimal access surgery to their patients.”